Abstract This Consensus Statement from an international, multidisciplinary workshop
sponsored by the Pituitary Society offers evidence-based graded consensus …

Dopamine agonists are usually very effective in the treatment of prolactinomas.
Nonetheless, a subset of individuals does not respond satisfactorily to these agents, and this …

Prolactinomas are the most common pituitary adenomas (approximately 40% of cases), and
they represent an important cause of hypogonadism and infertility in both sexes. The …

Giant prolactinomas are rare tumours, representing only 2–3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

Giant pituitary adenomas comprise about 6–10% of all pituitary tumors. They are mostly
clinically non-functioning adenomas and occur predominantly in males. The presenting …

Compression of the optic chiasm causes an optic neuropathy that may be associated with
reversible visual loss often immediately following surgical decompression. While the precise …

Hyperprolactinemia, defined by a level of serum prolactin above the standard upper limit of
normal range, is a common finding in clinical practice and prolactinomas are the main …

Context Prolactinomas in men are usually large and invasive, presenting with signs and
symptoms of hypogonadism and mass effects, including visual damage. Prolactin levels are …

Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of
the pituitary. Microprolactinomas (diameter< 10 mm) are frequently diagnosed in women …

Purpose To describe the clinical presentation and treatment outcomes in a nationwide
cohort of patients with giant prolactinomas. Methods Register-based study of patients with …